Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

Design and Synthesis of Ionic Liquid-Based Matrix Metalloproteinase Inhibitors (MMPIs): A Simple Approach to Increase Hydrophilicity and to Develop MMPI-Coated Gold Nanoparticles.

D'Andrea F, Nuti E, Becherini S, Cuffaro D, Husanu E, Camodeca C, De Vita E, Zocchi MR, Poggi A, D'Arrigo C, Cappello V, Gemmi M, Nencetti S, Chiappe C, Rossello A.

ChemMedChem. 2019 Jan 2. doi: 10.1002/cmdc.201800733. [Epub ahead of print]

PMID:
30600908
2.

Immunomodulatory properties of mesenchymal stromal cells: still unresolved "Yin and Yang".

Poggi A, Zocchi MR.

Curr Stem Cell Res Ther. 2018 Dec 4. doi: 10.2174/1574888X14666181205115452. [Epub ahead of print]

PMID:
30516112
3.

Synthesis and in vitro Evaluation of ADAM10 and ADAM17 Highly Selective Bioimaging Probes.

Camodeca C, Nuti E, Tosetti F, Poggi A, D'Arrigo C, Zocchi MR, Rossello A.

ChemMedChem. 2018 Oct 8;13(19):2119-2131. doi: 10.1002/cmdc.201800482. Epub 2018 Sep 12.

PMID:
30102846
4.

Corrigendum: Zoledronate Triggers Vδ2 T Cells to Destroy and Kill Spheroids of Colon Carcinoma: Quantitative Image Analysis of Three-Dimensional Cultures.

Varesano S, Zocchi MR, Poggi A.

Front Immunol. 2018 Jun 13;9:1343. doi: 10.3389/fimmu.2018.01343. eCollection 2018.

5.

Corrigendum: How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive.

Poggi A, Varesano S, Zocchi MR.

Front Immunol. 2018 Jun 11;9:1342. doi: 10.3389/fimmu.2018.01342. eCollection 2018.

6.

Targeting the Epidermal Growth Factor Receptor Can Counteract the Inhibition of Natural Killer Cell Function Exerted by Colorectal Tumor-Associated Fibroblasts.

Costa D, Venè R, Benelli R, Romairone E, Scabini S, Catellani S, Rebesco B, Mastracci L, Grillo F, Minghelli S, Loiacono F, Zocchi MR, Poggi A.

Front Immunol. 2018 May 29;9:1150. doi: 10.3389/fimmu.2018.01150. eCollection 2018.

7.

Zoledronate Triggers Vδ2 T Cells to Destroy and Kill Spheroids of Colon Carcinoma: Quantitative Image Analysis of Three-Dimensional Cultures.

Varesano S, Zocchi MR, Poggi A.

Front Immunol. 2018 May 8;9:998. doi: 10.3389/fimmu.2018.00998. eCollection 2018. Erratum in: Front Immunol. 2018 Jun 13;9:1343.

8.

Specific ADAM10 inhibitors localize in exosome-like vesicles released by Hodgkin lymphoma and stromal cells and prevent sheddase activity carried to bystander cells.

Tosetti F, Venè R, Camodeca C, Nuti E, Rossello A, D'Arrigo C, Galante D, Ferrari N, Poggi A, Zocchi MR.

Oncoimmunology. 2018 Jan 19;7(5):e1421889. doi: 10.1080/2162402X.2017.1421889. eCollection 2018.

9.

How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive.

Poggi A, Varesano S, Zocchi MR.

Front Immunol. 2018 Feb 19;9:262. doi: 10.3389/fimmu.2018.00262. eCollection 2018. Review. Erratum in: Front Immunol. 2018 Jun 11;9:1342.

10.

Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity.

Zocchi MR, Costa D, Venè R, Tosetti F, Ferrari N, Minghelli S, Benelli R, Scabini S, Romairone E, Catellani S, Profumo A, Poggi A.

Oncoimmunology. 2017 Jan 6;6(3):e1278099. doi: 10.1080/2162402X.2016.1278099. eCollection 2017.

11.

ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing.

Zocchi MR, Camodeca C, Nuti E, Rossello A, Venè R, Tosetti F, Dapino I, Costa D, Musso A, Poggi A.

Oncoimmunology. 2015 Dec 29;5(5):e1123367. doi: 10.1080/2162402X.2015.1123367. eCollection 2016 May.

12.

Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models.

Camodeca C, Nuti E, Tepshi L, Boero S, Tuccinardi T, Stura EA, Poggi A, Zocchi MR, Rossello A.

Eur J Med Chem. 2016 Mar 23;111:193-201. doi: 10.1016/j.ejmech.2016.01.053. Epub 2016 Jan 29.

PMID:
26871660
13.

Mesenchymal stromal cells as regulators of anti-tumour immune response.

Poggi A, Zocchi MR.

Indian J Med Res. 2015 Feb;141(2):139-42. No abstract available.

14.

γδ T Lymphocytes as a First Line of Immune Defense: Old and New Ways of Antigen Recognition and Implications for Cancer Immunotherapy.

Poggi A, Zocchi MR.

Front Immunol. 2014 Nov 11;5:575. doi: 10.3389/fimmu.2014.00575. eCollection 2014. Review.

15.

Mechanisms of tumor escape from immune system: role of mesenchymal stromal cells.

Poggi A, Musso A, Dapino I, Zocchi MR.

Immunol Lett. 2014 May-Jun;159(1-2):55-72. doi: 10.1016/j.imlet.2014.03.001. Epub 2014 Mar 20. Review.

PMID:
24657523
16.

NK cell autoreactivity and autoimmune diseases.

Poggi A, Zocchi MR.

Front Immunol. 2014 Feb 4;5:27. doi: 10.3389/fimmu.2014.00027. eCollection 2014. Review.

17.

How to exploit stress-related immunity against Hodgkin's lymphoma: Targeting ERp5 and ADAM sheddases.

Poggi A, Zocchi MR.

Oncoimmunology. 2013 Dec 1;2(12):e27089. Epub 2013 Dec 5. Review.

18.

Stress immunity in lymphomas: mesenchymal cells as a target of therapy.

Poggi A, Zocchi MR.

Front Biosci (Landmark Ed). 2014 Jan 1;19:281-90. Review.

PMID:
24389184
19.

Aminobisphosphonates prevent the inhibitory effects exerted by lymph node stromal cells on anti-tumor Vδ 2 T lymphocytes in non-Hodgkin lymphomas.

Musso A, Catellani S, Canevali P, Tavella S, Venè R, Boero S, Pierri I, Gobbi M, Kunkl A, Ravetti JL, Zocchi MR, Poggi A.

Haematologica. 2014 Jan;99(1):131-9. doi: 10.3324/haematol.2013.097311. Epub 2013 Oct 25.

20.

Selective role of mevalonate pathway in regulating perforin but not FasL and TNFalpha release in human Natural Killer cells.

Poggi A, Boero S, Musso A, Zocchi MR.

PLoS One. 2013 May 7;8(5):e62932. doi: 10.1371/journal.pone.0062932. Print 2013.

22.

Defective expression and function of the leukocyte associated Ig-like receptor 1 in B lymphocytes from systemic lupus erythematosus patients.

Colombo BM, Canevali P, Magnani O, Rossi E, Puppo F, Zocchi MR, Poggi A.

PLoS One. 2012;7(2):e31903. doi: 10.1371/journal.pone.0031903. Epub 2012 Feb 15. Erratum in: PLoS One. 2012;7(6): doi/10.1371/annotation/1ada33bd-76c7-4b66-906f-950b383111e8.

23.
24.

High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas.

Zocchi MR, Catellani S, Canevali P, Tavella S, Garuti A, Villaggio B, Zunino A, Gobbi M, Fraternali-Orcioni G, Kunkl A, Ravetti JL, Boero S, Musso A, Poggi A.

Blood. 2012 Feb 9;119(6):1479-89. doi: 10.1182/blood-2011-07-370841. Epub 2011 Dec 13.

25.

Modulating mesenchymal stromal cell function with cholesterol synthesis inhibitors.

Poggi A, Zocchi MR.

Curr Med Chem. 2011;18(34):5196-205. Review.

PMID:
22087820
26.

MF-59 adjuvant influence on the functions of gammadelta T cells in HIV-1+ adults immunized with influenza seasonal vaccine.

Fenoglio D, Zocchi MR, Parodi A, Durando P, Gabutitp G, Gasparini R, Poggi A.

J Prev Med Hyg. 2011 Sep;52(3):137-41.

PMID:
22010544
27.

Imatinib treatment induces CD5+ B lymphocytes and IgM natural antibodies with anti-leukemic reactivity in patients with chronic myelogenous leukemia.

Catellani S, Pierri I, Gobbi M, Poggi A, Zocchi MR.

PLoS One. 2011 Apr 18;6(4):e18925. doi: 10.1371/journal.pone.0018925.

28.

Down regulation of human natural killer cell-mediated cytolysis induced by blood transfusion: role of transforming growth factor-β(1), soluble Fas ligand, and soluble Class I human leukocyte antigen.

Ghio M, Contini P, Negrini S, Mazzei C, Zocchi MR, Poggi A.

Transfusion. 2011 Jul;51(7):1567-73. doi: 10.1111/j.1537-2995.2010.03000.x. Epub 2011 Jan 7.

PMID:
21214580
29.
30.

Differential survival of γδT cells, αβT cells and NK cells upon engagement of NKG2D by NKG2DL-expressing leukemic cells.

Poggi A, Zancolli M, Boero S, Catellani S, Musso A, Zocchi MR.

Int J Cancer. 2011 Jul 15;129(2):387-96. doi: 10.1002/ijc.25682. Epub 2010 Nov 3.

31.

Engagement of CD31 delivers an activating signal that contributes to the survival of chronic lymphocytic leukaemia cells.

Poggi A, Prevosto C, Catellani S, Rocco I, Garuti A, Zocchi MR.

Br J Haematol. 2010 Nov;151(3):252-64. doi: 10.1111/j.1365-2141.2010.08343.x. Epub 2010 Aug 31.

PMID:
20813004
33.

Vdelta1 T lymphocytes producing IFN-gamma and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans.

Fenoglio D, Poggi A, Catellani S, Battaglia F, Ferrera A, Setti M, Murdaca G, Zocchi MR.

Blood. 2009 Jun 25;113(26):6611-8. doi: 10.1182/blood-2009-01-198028. Epub 2009 Apr 24.

34.

Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate.

Poggi A, Catellani S, Garuti A, Pierri I, Gobbi M, Zocchi MR.

Leukemia. 2009 Apr;23(4):641-8. doi: 10.1038/leu.2008.354. Epub 2009 Jan 8.

PMID:
19151770
35.

Role of bone marrow stromal cells in the generation of human CD8+ regulatory T cells.

Poggi A, Zocchi MR.

Hum Immunol. 2008 Nov;69(11):755-9. doi: 10.1016/j.humimm.2008.08.278. Epub 2008 Sep 24. Review.

PMID:
18817823
36.

Lack of the leukocyte-associated Ig-like receptor-1 expression in high-risk chronic lymphocytic leukaemia results in the absence of a negative signal regulating kinase activation and cell division.

Poggi A, Catellani S, Bruzzone A, Caligaris-Cappio F, Gobbi M, Zocchi MR.

Leukemia. 2008 May;22(5):980-8. doi: 10.1038/leu.2008.21. Epub 2008 Feb 21.

PMID:
18288129
37.

Adhesion molecules and kinases involved in gammadelta T cells migratory pathways: implications for viral and autoimmune diseases.

Poggi A, Catellani S, Fenoglio D, Borsellino G, Battistini L, Zocchi MR.

Curr Med Chem. 2007;14(30):3166-70. Review.

PMID:
18220750
38.

Migratory pathways of gammadelta T cells and response to CXCR3 and CXCR4 ligands: adhesion molecules involved and implications for multiple sclerosis pathogenesis.

Poggi A, Zancolli M, Catellani S, Borsellino G, Battistini L, Zocchi MR.

Ann N Y Acad Sci. 2007 Jun;1107:68-78.

PMID:
17804534
39.

NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells.

Poggi A, Prevosto C, Zancolli M, Canevali P, Musso A, Zocchi MR.

Ann N Y Acad Sci. 2007 Aug;1109:47-57.

PMID:
17785290
40.

Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction.

Prevosto C, Zancolli M, Canevali P, Zocchi MR, Poggi A.

Haematologica. 2007 Jul;92(7):881-8.

41.
42.

In vivo apoptosis of CD8(+) lymphocytes in acute myeloid leukemia patients: involvement of soluble HLA-I and Fas ligand.

Contini P, Zocchi MR, Pierri I, Albarello A, Poggi A.

Leukemia. 2007 Feb;21(2):253-60. Epub 2006 Dec 14.

PMID:
17170722
43.
45.

Mechanisms of tumor escape: role of tumor microenvironment in inducing apoptosis of cytolytic effector cells.

Poggi A, Zocchi MR.

Arch Immunol Ther Exp (Warsz). 2006 Sep-Oct;54(5):323-33. Epub 2006 Oct 6. Review.

PMID:
17031467
46.

Expansion of Vdelta1 T lymphocytes producing IL-4 in low-grade non-Hodgkin lymphomas expressing UL-16-binding proteins.

Catellani S, Poggi A, Bruzzone A, Dadati P, Ravetti JL, Gobbi M, Zocchi MR.

Blood. 2007 Mar 1;109(5):2078-85. Epub 2006 Sep 14.

47.

ZAP-70 is expressed by normal and malignant human B-cell subsets of different maturational stage.

Scielzo C, Camporeale A, Geuna M, Alessio M, Poggi A, Zocchi MR, Chilosi M, Caligaris-Cappio F, Ghia P.

Leukemia. 2006 Apr;20(4):689-95.

PMID:
16482211
48.

Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: role of NKp30 and NKG2D receptors.

Poggi A, Prevosto C, Massaro AM, Negrini S, Urbani S, Pierri I, Saccardi R, Gobbi M, Zocchi MR.

J Immunol. 2005 Nov 15;175(10):6352-60.

49.

Cyclosporin A regulates human NK cell apoptosis induced by soluble HLA-I or by target cells.

Poggi A, Zocchi MR.

Autoimmun Rev. 2005 Nov;4(8):532-6. Review.

PMID:
16214091
50.

Regulation of gammadelta T cell survival by soluble HLA-I: involvement of CD8 and activating killer Ig-like receptors.

Poggi A, Contini P, Catellani S, Setti M, Murdaca G, Zocchi MR.

Eur J Immunol. 2005 Sep;35(9):2670-8.

Supplemental Content

Loading ...
Support Center